Reimagined Advertising Automation Stock IPOs on NASDAQ | AcuityAds
AcuityAds Holdings Inc (NASDAQ:ATY, TSE:AT) provides marketers with a one-stop solution for omnichannel digital advertising. In a world where advertisers are becoming very picky where they spend their money, Acuity has reimagined digital advertising automation to provide marketers with best-of-category returns on investment. Its journey automation technology, illumin™, closes the gap between advertising planning and execution.
AcuityAds journey automation technology has seen huge success since its launch, as seen in its latest financials. AcuityAds generated $27.5 million in Revenue (↑ 13.4% YoY).
“Once we launch illumin last year, we have a clear differentiator out there. And the excitement we are seeing because of illumin is through the roof. We launched it in Q4 of last year. We didnt even expect to have revenue until the second half of this year. We already had $1.5 million running on it in Q4, $3.2 million running in Q1. Q2 looking amazing as well. The adoption of illumin happened much larger than expected.” – AcuityAds CEO Tal Hayek
To build on the company’s success, AcuityAds recently launched a marketed public offering of $50M of its shares in the U.S. and Canada, representing the company’s IPO in the U.S.
Watch the full interview to understand AcuityAd’s differentiated direction of digital advertising, what the company plans on doing with its recent capital raise, and its stellar financials.
00:23 – What has driven 10x growth over the last decade?
01:08 – How illumin AI engine is superior to other platforms
03:06 – What AcuityAds will do with proceeds from capital raise?
03:58 – Different components of advertising platform
05:21 – Biggest competitors
06:31 – Brands AcuityAds work with
07:07 – How to maximize consumer journey
08:50 – Google ads
09:47 – Analyst guidance
10:15 – Revenue growth
Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.
Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.
Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.